Valeant Falls Below $80 for First Time in Two Years

  • 9 years ago
Nov. 5 -- Valeant Pharmaceuticals International Inc. dropped below $80 a share for the first time in more than two years as the drugmaker continued a slide that has seen the shares lose 70 percent of their value since their August peak. Bloombergs Drew Armstrong reports on Bloomberg Markets.

Recommended